期刊文献+

缬沙坦对豚鼠心肌缺血时去甲肾上腺素释放的影响 被引量:1

Effect of valsartan on cardiac norepinephrine release under ischemic conditions
下载PDF
导出
摘要 目的探讨在缺血条件下不同浓度缬沙坦对豚鼠离体心脏去甲肾上腺素(NE)释放的影响及机制。方法建立豚鼠离体心脏缺血模型,以高效液相色谱仪测定缬沙坦加入前后NE和二羟基苯乙二醇(DHPG)含量的变化,并探讨它们之间的关系。结果①在缺血条件下NE释放量较正常氧供时明显增加;②在缺血10min后,中、高浓度缬沙坦灌注组NE释放量较缺血前明显增加,并呈浓度依赖性,随缬沙坦灌注浓度增加NE释放明显增加;③在缺血10min后,中、高浓度缬沙坦灌注组DHPG释放量较缺血前明显减少,并呈浓度依赖性,随缬沙坦灌注浓度增加DHPG释放明显减少。结论缬沙坦促进豚鼠离体心脏短时间(10min)缺血条件下时的NE释放并呈剂量依赖性。 Objective To investigate the effects and mechanism of valsartan at different concentrations on cardiac norepinephrine release in isolated perfused guinea pig heart under ischemic conditions. Methods A guinea isehemie heart model was established. High-performance liquid chromatographywas used to determine the outflow of cardiac NE and dihydroxyphenylglyi col (DHPG) from isolated perfused guinea pig hearts. :Results ONE release was significantly increased under ischemic condition as compared with non-ischemie condition. ① After 10 min ischemia, NE release was significantly increased in valsartan middle and high concentration groups as corhpared with control group under non-ischemic condition in a concentration dependent manner, ② After 10 min isehemia, DHPG release was markedly decreased in valsartan middle and high concentration groups as compared with control group under non-ischemie condition in a concentration dependent manner. Conclusion Valsartan can promote norepinephrine release in a concentration depeadent manner during short-term ischemia (10 min).
出处 《华中医学杂志》 CAS 2005年第5期349-351,共3页 Central China Medical Journal
关键词 去甲肾上腺素 缬沙坦 心肌缺血 豚鼠 Norepinephrine Valsartan Myocardial isehemia
  • 相关文献

参考文献8

  • 1Robert R, Randi B, Christina J et al. Activation of rennin-angiotensin system in ischemic cardiac symoathetic nerve endings and its association with norepinephrine release. International Immunopharmacology,2002,2:1965.
  • 2Maruyama R, Hatta E, Robertet L et al. Norepinephrine release and ventricular fibrillation in myocardial ischemic/reperfusion: roles of angiotensin and bradykinin. Journal of Cardiovascular Pharmacology,1999,34:913.
  • 3Doreen R, Sebastian W, Cathy B et al. Effect of ACE-inhibitor ramiprilat and AT1-receptor antagonist candesartan on norepinephrine release:comparision between ischemic and nonischemic conditions.Journal of Cardiovascular Pharmacology,2002,40:641.
  • 4冯义柏,Seyf.,M.缺血与再注进电刺激引起大鼠心去甲肾上腺素释放的变化[J].中华医学杂志,1993,73(10):622-624. 被引量:12
  • 5Tsuyoshi A, Toji Y. Myocardial interstial norepinephrine and dihydroxyphenylglycol levers during ischemic and reperfusion. Cardiovascular Research,2001,49:78.
  • 6Hatt E, Maruyama R, Stuart J et al. Bradykinin promotes ischemic norepinephrine release in gunia pig ang human hearts. The Journal of Pharmacology and Therapeutics,1999,266:919.
  • 7李晔,赵志刚,陈旭,王景田,郭健,肖飞.高效液相色谱法测定缬沙坦的血浆药物浓度[J].药物分析杂志,2000,20(6):404-406. 被引量:11
  • 8Jun Yu, Gregory N, Linda T et al. Hybrid formation between the intracellular faces of the the bradykinin β2 and angiotensin Ⅱ AT1 receptors and signal transduction. International Immunopharmacology, 2002, 2:1807.

二级参考文献1

  • 1G. Flesch,P. Müller,P. Lloyd. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man[J] 1997,European Journal of Clinical Pharmacology(2):115~120

共引文献21

同被引文献14

  • 1姚峰,吕云霞,张彦周,刘朝霞,阎西艴.卡维地洛与比索洛尔对豚鼠缺血再灌注心室颤动的影响[J].郑州大学学报(医学版),2006,41(6):1080-1082. 被引量:2
  • 2Kuroko Y, Fujii T, Ymnazaki T, et al. Contribution of eatechol O- methyltransfemse to the removal of acceumulated interstitial catecholamines evoked by myocardial isehemia[ J]. Neurosci Lett,2005,388 (2):61.
  • 3Kurz T, Offner B, Schreieck J, et al. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts [ J]. Naunyn Sehmiedebergs Arch Pharmacol, 1995,352(5) :491.
  • 4Du XJ, Riemersma RA, Fox KA, et al. Propranolol and lidocaine inhibit neural norepinephrine release in hearts with increased extracellular potassium and ischemia[ J]. Circulation, 1993,88(4 Pt 1 ) : 1885.
  • 5Burgdorf C, Richardt D, Kurz T, et al. Adenosine inhibits norepinephrine release in the postischemic rat heart : the mechanism of neuronal stunning[J]. Cardiovasc Res,2001,49(4) :713.
  • 6Richardt D, Wolfrum S, Btittner C, et al. Effect of ACE-inhibitor ramiprilat and AT1-receptor antagonist candesartan on cardiac nore- pinephrine release: comparison between ischemic and nonischemic conditions[J]. J Cardiovasc Pharmacol,2002,dO(4) :641.
  • 7Xiao XH,Allen DG. The role of endogenous angiotensin II in ischemia, reperfusion and preconditioning of the isolated rat heart [ J ]. Pflugers Arch,2003,445(6) :643.
  • 8Cox SL, Sehelb V, Trendelenburg AU, et al. Enhancement of noradrenalme release by angiotensin II and bradykmin in mouse atria: evidence for cross-talk between G(q/11 )protein and G(i/o)protein-eoupled receptors[J]. Br J Pharmacol,2000, 129(6) : 1095.
  • 9Maseroel B, Pochet L, Laeckmann D. An overview of inhibitors of Na ( + )/n( + ) exchanger[J]. Eur J Med Chem,2003,38(6):547.
  • 10Silver RB, Poonwasi KS, Seyedi N, et al. Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings[J]. Proc Natl Acad Sci USA,2002,99(1) :501.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部